Special aspects of steroid hormone receptors’ expression in cases of cervical intraepithelial neoplasia depending on the papillomavirus infection progression in women with infertility
AbstractThe relevance of the study is contingent on insufficient study of the correlation between the reception of uterine cervix steroid hormones in cases of cervical intraepithelial neoplasia (CIN) and the level of human papilloma virus load in women with infertility. The goal of the research was to determine the peculiar features of cervix estrogen and progesterone receptors’ expression at different severity levels of cervical dysplasia, depending on the progression of Papilloma Viral Infection (PVI) in women with infertility. The material for the study was 157 cervical biopsy specimens: 62 – with a mild CIN; 53 – with a moderate CIN; 42 – with a severe CIN. For the immunohistochemical (IHC) test we used primary monoclonal antibodies to estrogen (ER) (clone 6F11, Novocastra) and progesterone receptors (PR) (clone 1A6, Novocastra) as well as the latest generation imaging system UltraVision LP (Lab Vision), chromogen (DAB (Lab Vision)). With PVI-associated CIN with infertility a redistribution of steroid receptor expression was determined; thus, estrogen receptors are characterised by reduction of epithelial and appearance of stromal reaction. But the progesterone receptors’ expression differs by appearance of positive epithelial expression with manifested reaction in the cervical stroma. Redistribution of steroid hormone reception under CIN is predominantly observed in women with tubal infertility. There was a significant decrease in the ER/PR index, with the lowest indicator in the group of patients with severe CIN. Negative expression of steroid hormone receptors is typical for high viral load, regardless of CIN severity level. Thus, in women with infertility, estrogen and progesterone receptors’ expression depends on CIN severity level and PVI progression level. Determining steroid hormone receptors’ expression under PVI-associated CIN in women with infertility may be used as an additional criterion for CIN severity level determination.
Alp, A. G. (2012). Genomic organization and proteins of human papillomavirus. Mikrobiyoloji Bulteni, 46(3), 507–515.
Ambühl, L. M. M., Villadsen, A. B., Baandrup, U., Dybkaer, K., & Sorensen, S. (2017). HPV16 E6 and E7 upregulate interferon-induced antiviral response genes ISG15 and IFIT1 in human trophoblast cells. Pathogens, 6(3), 40–52.
Baik, S., Mehta, F. F., & Chung, S.-H. (2019). Medroxyprogesterone acetate prevention of cervical cancer through progesterone receptor in a human papillomavirus transgenic mouse model. American Journal of Pathology, 189(12), 2459–2468.
Belokrinitskaia, T. E., Ponomareva, Y. N., Lomneva, G. M., Makkaveev, E. P., Vologdin, E. V., & Vershinin, O. V. (2005). Ekspressiya reczeptorov estrogenov i progesterona v normal’nykh i opukholevykh tkanyakh shejki matki [Expression of estrogen and progesterone receptors in normal and tumor cervical tissues]. Bulletin of the East Siberian Scientific Center of SB RAMS, 39, 7–12 (in Russian).
Belotserkovtseva, L. D., & Leskova, S. V. (2010). Sostoyanie epiteliya shejki matki u zhenshhin s patologiej shejki matki v zavisimosti ot inficzirovannosti papillomavirusnoj infekcziej [The condition of the cervical epithelium in women with cervix pathology depending on the papilloma virus infection contamination]. Bulletin of Surgut State University, Medicine, 1(4), 4–7 (in Russian).
Bershtein, L. M. (2000). Gormonal’nyj kanczerogenez [Hormonal carcinogenesis]. Science, Saint Petersburg (in Russian).
Bhat, P., Mattarollo, S. R., Gosmann, C., Frazer, I. H., & Leggatt, G. R. (2014). Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunological Reviews, 239(1), 85–98.
Blaskewicz, C. D., Pudney, J., & Anderson, D. J. (2011). Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biology of Reproduction, 85(1), 97–104.
Boda, D., Docea, A. O., Calina, D., Ilie, M. A., Caruntu, C., Zurac, S., Neagu, M., Constantin, C., Branisteanu, D. E., Voiculescu, V., Mamoulakis, C., Tzanakakis, G., Spandidos, D. A., Drakoulis, N., & Tsatsakis, A. M. (2018). Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (review). International Journal of Oncology, 52(3), 637–655.
Chung, S.-H. (2015). Targeting female hormone receptors as cervical cancer therapy. Trends in Endocrinology and Metabolism, 26(8), 399–401.
Churuksaeva, O. N., Asadchikova, O. N., Kolomiets, L. A., Stukanov, S. L., Vidiaeva, Y. G., Nikitina, E. G., & Urazova, L. N. (2010). Gormonal’nye faktory virus-assocziirovannogo raka shejki matki [Hormonal factors of virus-associated cervical cancer]. Tumours of the Female Reproductive System, 4, 54–57.
Coelho, F., Prado, J., Pereira Sobrinho, J. S., Hamada, G., Landman, G., Pinto, C. A., Nonogaki, S., & Villa, L. L. (2004). Estrogen and progesterone receptors in human papilloma virus-related cervical neoplasia. Brazilian Journal of Medical and Biological Research, 37(1), 83–88.
Dorokhova, O. V., Shponka, O. V., & Khanina, O. I. (2007). Ekspresiya receptoriv estrogenu i progesteronu v cervikal’nykh intraepitelial’nykh neoplaziyakh [Expression of estrogen and progesterone receptors in cervical intraepithelial neoplasia]. Morphologia, 1(2), 41–46 (in Ukrainian).
Elwood, V. E., & Craig, V. J. (2003). The estrogen receptor: A model for molecular medicine. Clinical Cancer Research, 9(6), 1980–1989.
Fontecha, N., Basaras, M., Hernáez, S., Andía, D., & Cisterna, R. (2016). Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. BMC Cancer, 16(1), 852–859.
Foresta, C., Noventa, M., De Toni, L., Gizzo, S., & Garolla, A. (2015). HPV-DNA sperm infection and infertility: From a systematic literature review to a possible clinical management proposal. Andrology, 3(2), 163–173.
Grigorian, O. R., Uzhegova, Z. A., & Andreeva, E. N. (2007). Rol’ endogennykh polovykh steroidov v geneze predrakovykh zabolevanij i raka shejki matki pri endokrinopatiyakh [The role of endogenous sex steroids in the genesis of precancerous diseases and cervical cancer under endocrinopathies]. Endocrinology Problems Journal, 53, 15–19 (in Russian).
Habbous, S., Pang, V., Eng, L., Xu, W., Kurtz, G., Liu, F. F., Mackay, H., Amir, E., & Liu, G. (2012). p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: A systematic review and meta-analysis. Clinical Cancer Research, 18(23), 6407–6415.
Hamid, N. A., Brown, C., & Gaston, K. (2009). The regulation of cell proliferation by the papillomavirus early proteins. Cellular and Molecular Life Sciences, 66(10), 1700–1717.
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996). Real-time quantitative PCR. Genome Research, 6, 986–994.
Henderson, B. E., & Feigelson, H. S. (2000). Hormonal carcinogenesis. Carcinogenesis, 21, 427–433.
Ikeda, K., & Inoue, S. (2004). Estrogen receptors and their downstream targets in cancer. Archives of Histology and Cytology, 67(5), 435–442.
Ikuo, K., Shingo, F., & Hirofumi, N. (2006). Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Cancer, 68(6), 1340–1350.
Kumar, M. M., Davuluri, S., Poojar, S., Mukherjee, G., Bajpai, A. K., Bafna, U. D., Devi, U. K., Kallur, P. P., Kshitish, A. K., & Jayshree, R. S. (2016). Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts: A transcriptomic study. Tumor Biology, 37, 4409–4420.
Mehta, F. F., Baik, S., & Chung, S.-H. (2017). Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model. Oncotarget, 8(2), 2372–2380.
Najmabadi, S., Schliep, K. C., Simonsen, S. E., Porucznik, C. A., Egger, M. J., & Stanford, J. B. (2020). Menstrual bleeding, cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled analysis of three cohorts. Paediatric and Perinatal Epidemiology, 34(3), 318–327.
Patel, B., Elguero, S., Thakore, S., Dahoud, W., Bedaiwy, M., & Mesiano, S. (2015). Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Human Reproduction Update, 21(2), 155–173.
Ramachandran, B. (2017). Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis. Endocrine-Related Cancer, 24(4), 99–108.
Rojas, J., Chávez-Castillo, M., Olivar, L. C., Calvo, M., Mejías, J., Rojas, M., Morillo, J., & Bermúdez, V. (2015). Physiologic course of female reproductive function: A molecular look into the prologue of life. Journal of Pregnancy, 2015, 715–735.
Samoilova, A. B., & Kostrova, E. V. (2009). Osobennosti ekspressii reczeptorov k estradiolu i progesteronu pri giperplaziyakh endometriya u zhenshhin s endokrinnym besplodiem [Features of estradiol and progesterone receptors expression in endometrial hyperplasia in women with endocrine infertility]. Obstetrics and Women’s Diseases Journal, 58(1), 38–43 (in Russian).
Son, J., Park, J. W., Lambert, P. F., & Chung, S.-H. (2014). Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice. Carcinogenesis, 35(2), 489–496.
Son, J., Park, Y., & Chung, S. H. (2018). Epithelial oestrogen receptor α is dispensable for the development of oestrogen-induced cervical neoplastic diseases. The Journal of Pathology, 245(2), 147–152.
Veropotvelian, P. N., Veropotvelian, N. P., Yaruchik, S. P. (2012). Sovremennye molekulyarnye metody diagnostiki papillomavirusnoj infekczii [Modern molecular methods of papillomavirus infection diagnosis]. Medical Aspects of Woman’s Health, 57, 10–14. (in Russian).
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.